Portrait of Capito, Shelley M

Capito, Shelley M

U.S. Senator WV Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
738
Buys / sells
47% / 52%
Last trade
Apr 17, 2026
Last filing
May 7, 2026

Latest disclosed trades

Latest 10 of 738
Ticker Type Traded
AAPL Sell Apr 17, 2026
CEG Sell Apr 17, 2026
AVGO Sell Apr 13, 2026
FDS Sell Mar 31, 2026
MA Buy Mar 28, 2026
FDS Sell Mar 26, 2026
FDS Sell Mar 25, 2026
PNC Buy Mar 12, 2026
AXP Buy Mar 11, 2026
ITW Sell Feb 24, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Capito, Shelley M stock trade activity

FilingIQ has indexed 738 congressional stock trade disclosures for Capito, Shelley M. The most recent disclosed transaction is dated Apr 17, 2026.

Across the full history, 348 purchases and 383 sales have been disclosed under the STOCK Act.

Top tickers traded by Capito, Shelley M

Frequently asked

How many stock trades has Capito, Shelley M disclosed?
FilingIQ tracks 738 Periodic Transaction Report disclosures for Capito, Shelley M, with the most recent dated Apr 17, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Capito, Shelley M a net buyer or net seller?
Across the disclosed trade history, 348 (47%) were purchases and 383 (52%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Capito, Shelley M come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.